Insights On Pharmaceutical Production

  1. Enhanced Flow Kit Performance With Leak And PUPSIT Testing 1/13/2026

    Sterile drug filtration demands rigorous integrity testing to prevent contamination. Learn how PUPSIT and in situ leak testing strengthen compliance with EU GMP Annex 1 and ensure reliable manufacturing.

  2. Accelerated Development Of Solid Oral Dosage Formulation For IND Submission 12/11/2024

    This paper highlights how the roller compaction process not only enhances efficiency but also improves the scalability of solid oral dosage production, supporting rapid development for regulatory approval.

  3. Achieving High Cell Purity With The CTS DynaCellect Magnetic Separation System 4/21/2026

    Learn how closed-system automation, combined with expert technical guidance and protocol optimization, turned a persistent manufacturing bottleneck into a reliable, scalable process.

  4. Top Safety Considerations In Biopharmaceutical Manufacturing 4/16/2025

    Understanding top safety concerns, from combustible material handling and chemical exposure to HPAPIs, is the first step toward preventing accidents in biopharmaceutical manufacturing environments.

  5. Streamlining Cell Line Development For Antibodies 8/27/2025

    Streamline your antibody production with a robust Cell Line Development strategy. Discover how automation, analytics, and digital tools accelerate development from clone selection to commercialization.

  6. Efficient Protein Purification Strategies 2/24/2026

    Examine two rapid, high‑throughput strategies for small‑scale protein separation, using either multimodal resins or ion exchange membranes to achieve efficient, low‑volume purification.

  7. A Collaboration With Fresenius Kabi BioPharm 5/19/2025

    Explore how biosimilar development is advancing through collaboration, innovative cell culture strategies, and the use of advanced media to meet biomanufacturing goals.

  8. Tackling High Costs Of Developing AAV-Based Therapeutics 8/27/2025

    Resolve monomers from dimers across AAV serotypes with a breakthrough solution that cuts sample use by up to 90%, accelerates development, and reduces costs—transforming gene therapy workflows.

  9. Accelerating Process Scale-Up From Benchtop To Commercialization- From Controller To Software 11/4/2025

    Discover strategies for optimizing process control, refining media selection, and ensuring safety through rigorous contaminant detection to mitigate development risks.

  10. Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview 4/16/2026

    From lab to production scale: a researcher's firsthand account of what bioreactor scaling and high-density perfusion really demand in practice.